|Publication number||US6166524 A|
|Application number||US 09/521,309|
|Publication date||26 Dec 2000|
|Filing date||9 Mar 2000|
|Priority date||9 Mar 2000|
|Also published as||EP1170810A2, EP1170810A3|
|Publication number||09521309, 521309, US 6166524 A, US 6166524A, US-A-6166524, US6166524 A, US6166524A|
|Inventors||Esther S. Takeuchi, Noelle M. Waite, Kenneth C. Syracuse|
|Original Assignee||Wilson Greatbatch Ltd.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (5), Referenced by (26), Classifications (19), Legal Events (8)|
|External Links: USPTO, USPTO Assignment, Espacenet|
1. Field of the Invention
The present invention generally relates to the conversion of chemical energy to electrical energy. More particularly, the present invention relates to the use of data collected from a discharging alkali metal/solid cathode cell to provide a "fuel gauge" for determining the state of charge of the cell. According to the present invention, the use of voltage recovery data from one load to a second, lighter load in a pulse discharging cell, particularly a Li/CFx cell, is used to estimate the depth-of-discharge (DOD) for the cell. The depth-of-discharge is directly related to the remaining discharge capacity. The use of the pulse discharge data as a fuel gauge according to the present invention is, therefore, particularly useful in an electrochemical cell powering an implantable medical device where the cell may discharge under a light load for extended periods of time interrupted by pulse discharge.
2. Prior Art
In a discharging electrochemical cell, especially an implantable cell, it is desirable to know the amount or quantity of available capacity that remains. This affords the physician an opportunity to schedule surgery for device replacement in a timely and orderly manner without causing undue or unnecessary harm to the patient. Up to now, attempts to determine the charge condition or consumed battery capacity in a pulse dischargeable cell have generally relied on a counter to tabulate the number of pulses delivered by the battery, and hence, the remaining capacity. Representative of these types of devices are U.S. Pat. Nos. 4,556,061 to Barreras et al. and 5,144,218 to Bosscha.
The present invention is not dependent on a raw or cumulative pulse count, but rather, the recovery rate from one load to a second, lighter load or to open circuit voltage (OCV) to determine the depth of discharge for the cell.
According to the present invention, the voltage recovery data from one load to a second, lighter load in a pulse discharging cell, particularly a Li/CFx cell, are used to calculate the depth-of-discharge (DOD) for the cell. In that respect, voltage recovery according to the present invention is determined from one load to a second, lighter load or from a loaded condition to open circuit voltage. Such load variations can occur in an implantable medical device wherein the cell may discharge for extended periods under a light load interrupted by pulse discharge.
The foregoing and additional advantages and characterizing features of the present invention will become clearly apparent upon a reading of the following detailed description together with the included drawings.
FIG. 1 is a schematic of an implantable medical device useful with the fuel gauge of the present invention.
FIG. 2 is a graph showing the typical pulse signature of a Li/CFx cell.
FIGS. 3 to 8 are graphs constructed from the ΔV/ΔT ratio versus % depth-of-discharge for Li/CFx cells under various discharge regimens.
As used herein, the term "pulse" means a short burst of electrical current of a greater amplitude than that of a current immediately prior to the pulse. A pulse train consists of at least two pulses of electrical current delivered in relatively short succession with or without open circuit rest between the pulses.
Referring now to the drawings, FIG. 1 shows a schematic embodiment of an electrochemical cell 10 according to the present invention provided as the power source for an implantable medical device 12. Representative medical devices include drug pumps, pacemakers, arterial defibrillators and neurostimulators, and the like. The cell 10 is connected to electronic circuitry 14 for the medical device 12. The electronics 14 enable the cell 10 to power the medical device 12 both at a relatively constant load 16 in a device monitoring mode, for example in a cardiac pacemaker for monitoring the heartbeat, and at a pulse load 18 during a device operating mode for charging a capacitor (not shown) or for delivering therapy.
An electrochemical cell that possesses sufficient energy density and discharge capacity required of implantable medical devices comprises an anode of anode active materials selected from Groups IA, IIA and IIIA of the Periodic Table of the Elements, including lithium, sodium, potassium, calcium, magnesium or their alloys, or any alkali metal or alkali-earth metal capable of functioning as an anode. Lithium is preferred and in that case the alloys and intermetallic compounds include, for example, Li--Si, Li--Al, Li--Mg, Li--Al--Mg, Li--B and Li--Si--B alloys and intermetallic compounds. The form of the anode may vary, but typically, the anode comprises a thin sheet or foil of the anode metal or alloy thereof, and a current collector contacted to the anode material. The current collector includes an extended tab or lead for connection to the negative terminal.
The cathode electrode comprises solid active materials such as are typically used in alkali metal/solid cathode electrochemical cells. Particularly preferred cathode active materials for use with the present invention are prepared from fluorine and carbon including graphitic and nongraphitic forms of carbon, such as coke, charcoal or activated carbon. The fluorinated carbon is represented by the formula (CFx)n wherein x varies between about 0.1 to 1.9 and preferably between about 0.5 and 1.2, and (C2 F)n wherein the n refers to the number of monomer units which can vary widely.
Other electrode active materials suitable for use with the present invention include a metal, a metal oxide, a metal sulfide and carbonaceous materials, and mixtures thereof. Such electrode active materials include, but are not limited to, manganese dioxide, copper silver vanadium oxide, silver vanadium oxide, copper vanadium oxide, titanium disulfide, copper oxide, copper sulfide, iron sulfide, iron disulfide and carbon, and mixtures thereof. No matter what active material is used, the cathode preferably comprises about 80 to about 99 weight percent of the electrode active material.
According to the present invention, the preferred cathode active mixture comprises CFx combined with a discharge promoter component such as acetylene black, carbon black and/or graphite. Metallic conductive diluents such as nickel, aluminum, titanium and stainless steel in powder form are also useful when mixed with the cathode active mixture of the present invention. Up to about 10 weight percent of the discharge promoter component/conductive diluent is added to the mixture to improve conductivity.
Solid cathode active components for incorporation into a cell according to the present invention may be prepared by rolling, spreading or pressing a mixture of one or more of the above listed electrode active materials, a discharge promoter component and/or one or more of the enumerated conductive diluents onto a cathode current collector with the aid of a binder material. Preferred binder materials include a powdered fluoro-resin such as powdered polytetrafluoroethylene (PTFE) or powdered polyvinylidene fluoride present at about 1 to about 5 weight percent of the electrode active material.
The cathode current collector includes a lead for connection to the positive cell terminal, and is preferably in the form of a thin sheet or metal screen, for example, a titanium, stainless steel, aluminum or nickel screen, preferably titanium, having the lead extending therefrom. Alternatively, prior to contact with the current collector, the cathode active mixture including the binder and the discharge promoter component/conductive diluent is formed into a free-standing sheet in a manner similar to that described in U.S. Pat. No. 5,543,249 to Takeuchi et al., which is assigned to the assignee of the present invention and incorporated herein by reference.
Cathodes prepared as described above may be in the form of a strip wound with a corresponding strip of anode material in a structure similar to a "jellyroll", or in the form of one or more plates operatively associated with at least one or more plates of anode material as in a prismatic configuration. Electrode assemblies having a bobbin shape, a button configuration and the like are also useful with the present invention.
The electrochemical cell of the present invention further includes a separator disposed intermediate the Group IA, IIA and IIIA anode and the cathode to provide physical separation therebetween. The separator is of electrically insulative material and the separator material also is chemically unreactive with the anode and cathode active materials and both chemically unreactive with and insoluble in the electrolyte. In addition, the separator material has a degree of porosity sufficient to allow flow therethrough of the electrolyte during the electrochemical reaction of the electrochemical cell. Illustrative separator materials include woven and non-woven fabrics of polyolefinic fibers including polyvinylidene fluoride, polyethylenetetrafluoroethylene, and polyethylenechlorotrifluoroethylene laminated or superposed with a polyolefinic or fluoropolymeric microporous film, non-woven glass, glass fiber materials and ceramic materials. Suitable microporous films include a polytetrafluoroethylene membrane commercially available under the designation ZITEX (Chemplast Inc.), a polypropylene membrane commercially available under the designation CELGARD (Celanese Plastic Company, Inc.) and a membrane commercially available under the designation DEXIGLAS (C.H. Dexter, Div., Dexter Corp.).
The electrochemical cell of the present invention further includes a nonaqueous, ionically conductive electrolyte which serves as a medium for migration of ions between the anode and the cathode electrodes during the electrochemical reactions of the cell. The electrochemical reaction at the electrodes involves conversion of ions in atomic or molecular forms which migrate from the anode to the cathode. Thus, nonaqueous electrolytes suitable for the present invention are substantially inert to the anode and cathode materials, and they exhibit those physical properties necessary for ionic transport, namely, low viscosity, low surface tension and wettability.
A suitable electrolyte has an inorganic or organic, tonically conductive salt dissolved in a nonaqueous solvent, and more preferably, the electrolyte includes an ionizable alkali metal salt dissolved in a mixture of aprotic organic solvents comprising a low viscosity solvent and a high permittivity solvent or, a single solvent. The ionically conductive salt serves as the vehicle for migration of the anode ions to intercalate or react with the cathode active material. In a solid cathode/electrolyte system, the preferred ion-forming alkali metal salt is similar to the alkali metal comprising the anode. Examples of salts useful with the present invention include LiPF6, LiAsF6, LiSbF6, LiBF4, LiAlC4, LiO2, LiGaCl4, LiSO3 F, LiB(C6 H5)4, LiClO4, LiC(SO2 CF3)3, LiSCN, LiO3 SCF2 CF3, LiC6 F5 SO3, LiO2 CCF3, LiN(SO2 CF3)2 and LiCF3 SO3, and mixtures thereof.
Low viscosity solvents include tetrahydrofuran (TFH), methyl acetate (MA), diglyme, trigylme, tetragylme, dimethyl carbonate (DMC), 1,2-dimethoxyethane (DME), diethyl carbonate, diisopropylether, 1,2-diethoxyethane (DEE), 1-ethoxy, 2-methoxyethane (EME), dipropyl carbonate (DPC), ethyl methyl carbonate (EMC), methyl propyl carbonate (MPC) and ethyl propyl carbonate (EPC), and mixtures thereof, and high permittivity solvents include cyclic carbonates, cyclic esters and cyclic amides such as propylene carbonate (PC), butylene carbonate (BC), ethylene carbonate (EC), acetonitrile, dimethyl sulfoxide, dimethyl formamide, dimethyl acetamide, γ-valerolactone, γ-butyrolactone (GBL) and N-methylpyrrolidinone (NMP) and mixtures thereof. In the preferred electrochemical cell comprising the Li/CFx couple, the preferred electrolyte is 1.0M to 1.4M LiBF4 in γ-butyrolactone (GBL).
The preferred form of the electrochemical cell of the present invention is a case-negative design wherein the anode/cathode couple is provided in a prismatic configuration inserted into a conductive metal casing such that the casing, a header thereof, or both are connected to the anode current collector and serve as the negative cell terminal, as is well known to those skilled in the art. A preferred material for the casing is titanium although stainless steel, nickel and aluminum are suitable. The casing header has a sufficient number of openings to accommodate a glass-to-metal seal terminal pin feedthrough for the cathode electrode. An additional opening is provided for electrolyte filling. After the prismatic electrode assembly is inserted into the casing and the casing header is secured thereto, the cell is filled with the electrolyte solution described hereinabove and hermetically sealed such as by close-welding a stainless steel plug over the fill hole, but not limited thereto. The cell of the present invention can also be constructed in a case-positive design.
The following example describes the manner and process of manufacturing an electrochemical cell according to the present invention, and it sets forth the best mode contemplated by the inventors of carrying out the invention, but it is not to be construed as limiting.
To closely mimic the conditions present in an implantable medical device, a test was conducted to estimate the depth of discharge for a Li/CFx cell where the total of pulse length and recovery interval (combined) was less than 0.83 seconds (corresponding to 72 beats per minute). The present example considers 0.50 seconds and 0.68 seconds recovery times.
Twenty lithium/carbon monofluoride (Li/CFx) cells commercially available under model no. 9424 from Wilson Greatbatch Ltd., Clarence, N.Y., the assignee of the present invention, were selected from production inventory for pulse discharge testing. These cells have a half-round profile with external dimensions of 45 mm×22 mm×5 mm and a theoretical capacity of 1.32 Ah. The selected Li/CFx cells are fabricated for use in implantable medical applications and they are capable of providing currents in the microamp to milliamp range while offering high energy density, long shelf life, and low impedance throughout cell life. The Li/CFx couple is characterized by a relatively flat voltage discharge profile.
First, the cells were discharged at 37° C. for 9 hours under a 1.5 kohm constant resistance load during an initial predischarge period. The predischarge period depleted the cells of approximately 1% of their theoretical capacity. Following this constant resistance portion of the regime, the cells were placed on open circuit storage for one week at 37° C., after which time the cells were subjected to a 10 mA pulse train. This pulse train consisted of four, 10 second pulses, with 15 second rest intervals between pulses.
Next, 100 kohm loads were soldered to each of the cells. All twenty cells were then pulse discharged at 37° C. according to the following regime:
1) Pulse train 1 was applied to the cells immediately (one cell at a time) under the 100 kohm background load. Subsequent pulse trains were applied every 0.06 Ah.
2) As presented in Table 1, each pulse train consisted of 9 pulses applied in parallel with the 100 kohm load that had been soldered to the cells. However, the maximum contribution of the 100 kohm load was calculated to be approximately 28 microamps. Therefore, the stated pulse amplitudes do not account for the 100 kohm load.
TABLE 1______________________________________Pulse # Pulse Length (sec) Pulse Amplitude (mA)______________________________________1 0.02 0.52 0.02 53 0.02 204 0.2 0.55 0.2 56 0.2 207 2 0.58 2 59 2 20______________________________________
3) An additional 5 kohm background load was applied between pulse trains in order to accelerate discharge. This load was removed for each pulse train application, starting with train 2. The actual drain experienced by the cells as a result of the 5 kohm load between pulse trains was approximately 4.76 kohms because the 5 kohm load was applied in parallel with the 100 kohm load previously soldered to the cells.
4) As soon as one of the cells delivered 0.06 Ah under background load since the end of the previous pulse train, the 5 kohm load was removed from all of the cells simultaneously, then all of the cells received one pulse train 24 hours later (i.e., the cells were pulsed one at a time following a 24-hour recovery period under 100 kohm background load), then the 5 kohm load was reapplied to all of the cells until the next pulse train.
5) The time between pulses within a train was 5 minutes (typical).
6) The end-of-life (EOL) cutoff was 1.0V under 5 mA pulse.
The cells reached end-of-life during pulse trains 22 or 23.
FIG. 2 is a graph showing the typical pulse signature of a Li/CFx cell (curve 30) wherein the pulse length is equal to (T2-T1) and recovery time is equal to (T3-T2). Voltage change is equal to (V2-V1). In this example, pulse application and voltage recovery [(T2-T1) plus (T3-T2)] were required to be within a total of 0.83 seconds (corresponding to 72 heartbeats per minute). FIGS. 3 to 8 are graphs showing the value of ΔV/ΔT=(V2-V1)/(T3-T2) as a function of DOD for the three pulse amplitudes set forth in Table 1.
In FIG. 3, all of the curves were constructed from voltage recovery under a 0.5 mA pulse, 0.5 seconds after pulse completion wherein curve 32 was constructed from the 0.02 seconds pulse length, curve 34 was constructed from the 0.2 seconds pulse length and curve 36 was constructed from the 2.0 seconds pulse length.
In FIG. 4, all of the curves were constructed from voltage recovery under a 0.5 mA pulse, 0.68 seconds after pulse completion wherein curve 38 was constructed from the 0.02 seconds pulse length, curve 40 was constructed from the 0.2 seconds pulse length and curve 42 was constructed from the 2.0 seconds pulse length.
In FIG. 5, all of the curves were constructed from voltage recovery under a 5.0 mA pulse, 0.5 seconds after pulse completion wherein curve 44 was constructed from the 0.02 seconds pulse length, curve 46 was constructed from the 0.2 seconds pulse length and curve 48 was constructed from the 2.0 seconds pulse length.
In FIG. 6, all of the curves were constructed from voltage recovery under a 5.0 mA pulse, 0.68 seconds after pulse completion wherein curve 50 was constructed from the 0.02 seconds pulse length, curve 52 was constructed from the 0.2 seconds pulse length and curve 54 was constructed from the 2.0 seconds pulse length.
In FIG. 7, all of the curves were constructed from voltage recovery under a 20 mA pulse, 0.5 seconds after pulse completion wherein curve 56 was constructed from the 0.02 seconds pulse length, curve 58 was constructed from the 0.2 seconds pulse length and curve 60 was constructed from the 2.0 seconds pulse length.
In FIG. 8, all of the curves were constructed from voltage recovery under a 20 mA pulse, 0.68 seconds after pulse completion wherein curve 62 was constructed from the 0.02 seconds pulse length, curve 64 was constructed from the 0.2 seconds pulse length and curve 66 was constructed from the 2.0 seconds pulse length.
The requirement in this example that the pulse length (T2-T1) and recovery time (T3-T2) must be less than 0.83 seconds excludes from consideration those pulses having a 2 second pulse length, namely, curves 36, 42, 48, 54, 60 and 66, as well as those pulses having a 0.2 second pulse length with a 0.68 second recovery, namely, curves 40, 52 and 64.
The fuel gauge methodology used in this example assumes recording ΔV/ΔT at least once every 5% to 10% DOD (computed), where:
% Depth of Discharge=[(delivered capacity/theoretical capacity)*100].
The methodology steps to determine DOD when using a 0.5 mA or 5 mA pulse are as follows:
1. Apply the pulse for the appropriate seconds; record V1 and T2.
2. Allow 0.5 or 0.68 seconds for recovery; record V2 and T3.
3. Compute ΔV/ΔT=(V2-V1)/(T3-T2).
4. Perform a trend analysis of ΔV/ΔT as a function of DOD using a minimum of three points.
5. Compare against FIGS. 3 and 4 (for a 0.5 mA pulse) or FIGS. 5 and 6 (for a 5 mA pulse).
If the trend is negative (decreasing), the cell is in the initial stage of its life (DOD<25%).
If the trend is near zero (flat), the cell is in the middle-of-life area (25%<DOD<50%).
If the trend is positive (increasing), the cell is in the latter stage of its life (DOD>50%). At this point, ΔV/ΔT monitoring should be coupled with discharge voltage monitoring.
This methodology, appropriate for 0.5 mA and 5.0 mA pulse amplitudes, must be modified to allow for use of a 20 mA pulse. Therefore, the methodology steps to determine DOD using a 20 mA pulse are as follows:
1. Apply the pulse for the appropriate seconds; record V1 and T2.
2. Allow 0.5 or 0.68 seconds for recovery; record V2 and T3.
3. Compute ΔV/ΔT=(V2-V1)/(T3-T2).
4. Perform a trend analysis of ΔV/ΔT as a function of DOD using a minimum of three points.
5. Compare against FIGS. 7 and 8.
If the trend is negative (decreasing), the cell is in the initial stage of its life (DOD<20%).
If the trend is near zero (flat) and the pulse length=0.02 seconds, the cell is in its middle-of-life area (20%<DOD<60%) or, if the pulse length=0.2 seconds, the cell is in a transition area (18%<DOD<23%).
If the trend is positive (increasing) and the pulse length=0.02 seconds, the cell is in the latter stage of its life (DOD>60%) or, if the pulse length=0.2 seconds, the cell is beyond the transition stage of its life (DOD>25%). Since (ΔV/ΔT) is nearly monotonic, DOD may be read directly from FIGS. 7 and 8. When the trend is positive, ΔV/ΔT monitoring should be coupled with discharge voltage monitoring.
Thus, the present invention describes a method for determining the remaining discharge capacity in an alkali metal cell powering an electronic device such as an implantable medical device. While the example is directed to Li/CFx cells, the method for determining the remaining discharge capacity according to the present invention is believed to be applicable to all pulse dischargeable alkali metal/solid cathode cells. Exemplary electrochemical couples include Li/SVO, Li/CSVO and Li/MnO2 as well as lithium and the other cathode active materials described hereinabove. Such a "fuel gauge" is useful for determining and planning elective surgery when the power source for the medical device is approaching its end-of-life and needs to be replaced.
It is appreciated that various modifications to the inventive concepts described herein may be apparent to those of ordinary skill in the art without departing from the spirit and scope of the present invention as defined by the appended claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4556061 *||12 Mar 1985||3 Dec 1985||Cordis Corporation||Cardiac pacer with battery consumption monitor circuit|
|US4607932 *||26 Apr 1985||26 Aug 1986||Canon Kabushiki Kaisha||Battery checking device|
|US5144218 *||13 Nov 1990||1 Sep 1992||U.S. Philips Corporation||Device for determining the charge condition of a battery|
|US5284719 *||8 Jul 1992||8 Feb 1994||Benchmarq Microelectronics, Inc.||Method and apparatus for monitoring battery capacity|
|US5357203 *||8 Jul 1992||18 Oct 1994||Benchmarq Microelectronics, Inc.||Battery monitoring circuit for operating with high battery discharge rates|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US6377850 *||9 Mar 2000||23 Apr 2002||Wilson Greatbatch Ltd.||Fuel gauge for an alkali metal electrochemical cell|
|US6930468||9 Sep 2003||16 Aug 2005||Wilson Greatbatch Technologies, Inc.||Discharge methodologies for optimizing the performance of lithium/silver vanadium oxide cells|
|US7026791 *||22 Jan 2004||11 Apr 2006||Wilson Greatbatch Technologies, Inc.||Electrochemical treatment method to reduce voltage delay and cell resistance in lithium/silver vanadium oxide cells|
|US7092830 *||23 Mar 2005||15 Aug 2006||Wilson Greatbatch Technologies, Inc.||Method for estimating long term end-of-life characteristics using short-term data for lithium/silver vanadium oxide cells|
|US7194308||12 Nov 2003||20 Mar 2007||Cardiac Pacemakers, Inc.||System and method for monitoring or reporting battery status of implantable medical device|
|US7239146 *||11 Jul 2003||3 Jul 2007||Cardiac Pacemakers, Inc.||Indicator of remaining energy in storage cell of implantable medical device|
|US7263449 *||17 Dec 2004||28 Aug 2007||Greatbatch Ltd.||Method for determining poor performing cells|
|US8198863||22 Oct 2007||12 Jun 2012||Maxim Integrated Products, Inc.||Model-based battery fuel gauges and methods|
|US8203305 *||2 Jul 2008||19 Jun 2012||Maxim Integrated Products, Inc.||Enhanced voltage-based fuel gauges and methods|
|US8338012||5 Aug 2011||25 Dec 2012||Dow Kokam France Sas||Method for managing the heat in an electric battery|
|US8395358 *||5 Aug 2011||12 Mar 2013||Dow Kokam France Sas||Method for managing the heat in an electric battery|
|US8502504||17 Feb 2011||6 Aug 2013||Maxim Integrated Products, Inc.||Model-based battery fuel gauges and methods|
|US8598849 *||5 Mar 2013||3 Dec 2013||Apple Inc.||In-situ battery health detector and end-of-life indicator|
|US8643331 *||13 Jun 2012||4 Feb 2014||Maxim Integrated Products, Inc.||Enhanced voltage-based fuel gauges and methods|
|US9035616||5 Dec 2011||19 May 2015||Maxim Integrated Products, Inc.||State based full and empty control for rechargeable batteries|
|US20040051504 *||9 Sep 2003||18 Mar 2004||Kenneth Syracuse||Discharge methodologies for optimizing the performance of lithium/silver vanadium oxide cells|
|US20040151976 *||22 Jan 2004||5 Aug 2004||Marcus Palazzo||Electrochemical treatment method to reduce voltage delay and cell resistance in lithium/silver vanadium oxide cells|
|US20050007073 *||11 Jul 2003||13 Jan 2005||James Kristofer J.||Indicator of remaining energy in storage cell of implantable medical device|
|US20050102005 *||12 Nov 2003||12 May 2005||Krig David B.||System and method for monitoring or reporting battery status of implantable medical device|
|US20050216212 *||23 Mar 2005||29 Sep 2005||Kenneth Syracuse||Method for estimating long term end-of-life characteristics using short-term data for lithium/silver vanadium oxide cells|
|US20120025785 *||2 Feb 2012||Dow Kokam France Sas||Method for managing the heat in an electric battery|
|US20120299556 *||29 Nov 2012||Tomoyasu Ishikawa||Deterioration degree determining apparatus|
|EP1132991A2 *||1 Mar 2001||12 Sep 2001||Wilson Greatbatch Limited||Fuel gauge for an alkali metal electrochemical cell|
|EP1170810A2 *||1 Mar 2001||9 Jan 2002||Wilson Greatbatch Ltd.||Alternate fuel gauge for an alkali metal electrochemical cell|
|EP1306686A2 *||23 Oct 2002||2 May 2003||Wilson Greatbatch Technologies, Inc.||Method for determining poor performing cells|
|EP1411578A1 *||9 Sep 2003||21 Apr 2004||Wilson Greatbatch Technologies, Inc.||Discharge methodologies for optimizing the performance of alkali metal/silver vanadium oxide cells|
|U.S. Classification||320/132, 320/161|
|International Classification||H01M6/50, H01M4/66, H01M6/16, H01M4/62, H01M10/44, G01R31/36, A61N1/08, H01M10/48, H01M4/58|
|Cooperative Classification||Y02E60/122, H01M6/50, H01M10/448, H01M6/16, H01M10/44, H01M4/5835|
|European Classification||H01M6/50, H01M10/44|
|9 Mar 2000||AS||Assignment|
|31 Jan 2001||AS||Assignment|
|19 Mar 2004||FPAY||Fee payment|
Year of fee payment: 4
|5 Jul 2007||AS||Assignment|
|22 Nov 2007||AS||Assignment|
Owner name: MANUFACTURERS AND TRADERS TRUST COMPANY,NEW YORK
Free format text: SECURITY INTEREST;ASSIGNOR:GREATBATCH LTD.;REEL/FRAME:020571/0205
Effective date: 20070522
|7 Jul 2008||REMI||Maintenance fee reminder mailed|
|26 Dec 2008||LAPS||Lapse for failure to pay maintenance fees|
|17 Feb 2009||FP||Expired due to failure to pay maintenance fee|
Effective date: 20081226